July 6 (Reuters) - Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are ...
New research offers fresh hope to patients with colorectal cancer, as advances in liquid biomarker technologies are ...
Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results